𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Correlation between soluble serum CD16 (sCD16) levels and disease stage in patients with multiple myeloma

✍ Scribed by C. Mathiot; J. -L. Teillaud; M. Elmalek; V. Mosseri; L. Euller-Ziegler; A. Daragon; B. Grosbois; J. -L. Michaux; T. Facon; J. -F. Bernard; B. Duclos; M. Monconduit; W. H. Fridman


Publisher
Springer
Year
1993
Tongue
English
Weight
986 KB
Volume
13
Category
Article
ISSN
0271-9142

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Elevated serum concentration of hepatocy
✍ M.G. Alexandrakis; F.H. Passam; A. Sfiridaki; E. Kandidaki; P. Roussou; D.S. Kyr πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 77 KB πŸ‘ 2 views

## Abstract Hepatocyte growth factor (HGF) has been shown to be involved in angiogenesis, epithelial cell proliferation, and osteoclast activation. HGF and its receptor are expressed on myeloma cell lines and could be involved in the pathogenesis of bone destruction in multiple myeloma (MM). The ai

Urinary N-telopeptide levels in multiple
✍ M. G. Alexandrakis; D. S. Kyriakou; F. H. Passam; N. Malliaraki; I. G. Vlachonik πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 92 KB

## Abstract Urinary cross‐linked N‐telopeptide of type I collagen (NTx) has been reported to be a sensitive and specific marker of bone resorption in multiple myeloma (MM). In this study, we measured the levels of NTx in 30 newly diagnosed MM patients and 25 controls. We examined its association wi

Soluble and membrane levels of molecules
✍ Martin Perez-Andres; Julia Almeida; Marta Martin-Ayuso; Natalia De Las Heras; Ma πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 323 KB πŸ‘ 1 views

## Abstract Clonal plasma cells (PC) from different types of monoclonal gammopathies (MG) display distinct phenotypes consistent with an increased antigen‐presentation and T‐cell costimulation in MG of undetermined significance that deteriorates in malignant conditions. Expression of other cell sur

Association between serum levels of solu
✍ Robert A. Burger; Kathleen M. Darcy; Philip J. DiSaia; Bradley J. Monk; Elizabet πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 209 KB πŸ‘ 1 views

## Abstract ## BACKGROUND A prospective study was undertaken within the Gynecologic Oncology Group to determine whether serum levels of soluble tumor necrosis factor receptors I (sTNFR‐I) and II (sTNFR‐II), alone or in combination with CA 125, were associated with clinicopathologic characteristics